Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

657
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
657
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

5.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic impact of tau versus amyloid PET in patients with cognitive symptoms.

Brain : a journal of neurology·2026
Same author

Chinese stroke association guidelines on construction of direct transfer to angiography suite.

Stroke and vascular neurology·2026
Same author

Brain endothelial cell-derived extracellular vesicles (c-BEEVs) as a promising biomarker for brain vascular pathology and cognitive decline.

Nature aging·2026
Same author

Endovascular treatment for symptomatic intracranial artery stenosis: current strategies and future challenges.

Stroke and vascular neurology·2026
Same author

Genetic Spectrum and Phenotypic Variability in Chinese Patients with Multisystem Proteinopathy and Related Disorders.

Degenerative neurological and neuromuscular disease·2026
Same author

Effect of a regional guideline-education initiative on dual antiplatelet therapy use in minor non-cardioembolic stroke: a pre-post analysis from the Shanghai Stroke Service System.

Stroke and vascular neurology·2026

Related Experiment Video

Updated: Jun 18, 2025

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

21.9K

Should patients with minor strokes be given thrombolytics?

Xun Wang1, Yi Dong2, Qiang Dong1

  • 1Department of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China.

Stroke and Vascular Neurology
|August 3, 2024
PubMed
Summary

Thrombolysis is not superior to antiplatelet therapy for minor non-disabling strokes. Reviewing published studies on thrombolysis for minor stroke patients is crucial for clinical practice.

Keywords:
AsprinIschemic StrokeStrokeThrombolysis

More Related Videos

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.0K
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

2.7K

Related Experiment Videos

Last Updated: Jun 18, 2025

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

21.9K
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.0K
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

2.7K

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Clinical Trials

Background:

  • Tissue-type plasminogen activator (thrombolysis) is underutilized in mild stroke cases (29-43%).
  • Previous research indicated poor outcomes for some patients with mild strokes not receiving thrombolysis.
  • Global stroke guidelines now advocate for thrombolysis in minor yet disabling strokes.

Conclusions:

  • Thrombolysis is not demonstrably more effective than antiplatelet therapy for minor non-disabling acute ischemic strokes.
  • The findings suggest a need to re-evaluate current guidelines and clinical practices regarding thrombolysis for mild stroke presentations.
  • Further research may be warranted to define optimal treatment strategies for this patient subgroup.